CD4 and neoplasm: CD8+ T lymphocytes are known for their cytotoxic effects against tumor cells, whereas CD4+ T lymphocytes are recognized for their robust anti-tumor immune responses (Huang et al., 2022; Takeuchi & Saito, 2017; Tsukumo & Yasutomo, 2018).